Iktos leverages AI and robotics to transform drug discovery, integrating Generative AI with automated synthesis and testing to accelerate development of new treatments.
peer of
investor of
competitor of
Metrics
marketPRIVATE
msh_idAI:IKTOS
localefr
websitehttps://iktos.ai/
source_ref58ebfea1-35b1-4fef-8aae-5c7ebb451424
products_or_servicesAI-driven drug design, retrosynthesis planning, autonomous lab automation, drug candidate development, collaborative drug discovery.
France